专业问题：非酒精性脂肪性肝炎纤维化患者应接受减重手术作为主要治疗方法吗？
PRO: Should patients with nonalcoholic steatohepatitis fibrosis undergo bariatric surgery as primary treatment?
作者信息
Orekondy Nayantara, Lee David, Malik Raza
机构信息
Liver Center Division of Gastroenterology and Hepatology Tufts Medical Center Boston Massachusetts USA.
Division of Gastroenterology & Hepatology University of Maryland Medical Center Baltimore Maryland USA.
出版信息
Clin Liver Dis (Hoboken). 2022 Jul 16;20(1):5-8. doi: 10.1002/cld.1224. eCollection 2022 Jul.
Abstract
Content available: Audio Recording.
摘要
内容提供
音频记录。
相似文献
1
PRO: Should patients with nonalcoholic steatohepatitis fibrosis undergo bariatric surgery as primary treatment?专业问题：非酒精性脂肪性肝炎纤维化患者应接受减重手术作为主要治疗方法吗？
Clin Liver Dis (Hoboken). 2022 Jul 16;20(1):5-8. doi: 10.1002/cld.1224. eCollection 2022 Jul.
2
CON: Should patients with nonalcoholic steatohepatitis fibrosis undergo bariatric surgery as a primary treatment?反对观点：非酒精性脂肪性肝炎纤维化患者是否应将减肥手术作为主要治疗方法？
Clin Liver Dis (Hoboken). 2022 Jul 22;20(1):9-12. doi: 10.1002/cld.1226. eCollection 2022 Jul.
3
Remission of nonalcoholic steatohepatitis after bariatric surgery: a single referral center cohort study.减重手术后非酒精性脂肪性肝炎的缓解：单转诊中心队列研究。
Surg Obes Relat Dis. 2024 May;20(5):482-489. doi: 10.1016/j.soard.2023.10.015. Epub 2023 Nov 7.
4
The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis.减重手术和内镜减重治疗在非酒精性脂肪性肝炎中的作用
Clin Liver Dis. 2023 May;27(2):413-427. doi: 10.1016/j.cld.2023.01.009. Epub 2023 Feb 26.
5
Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis.减重手术可长期解决非酒精性脂肪性肝炎并使肝纤维化消退。
Gastroenterology. 2020 Oct;159(4):1290-1301.e5. doi: 10.1053/j.gastro.2020.06.006. Epub 2020 Jun 15.
6
Nonalcoholic fatty liver disease in severe obese patients, subjected to bariatric surgery.接受减肥手术的重度肥胖患者的非酒精性脂肪性肝病
Arq Gastroenterol. 2013 Oct-Dec;50(4):285-9. doi: 10.1590/S0004-28032013000400009.
7
The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.减肥手术在非酒精性脂肪性肝病和非酒精性脂肪性肝炎中的作用。
Expert Rev Gastroenterol Hepatol. 2017 Sep;11(9):797-811. doi: 10.1080/17474124.2017.1355731. Epub 2017 Jul 21.
8
Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.接受减肥手术的日本病态肥胖患者中非酒精性脂肪性肝炎的患病率。
J Gastroenterol. 2016 Mar;51(3):281-9. doi: 10.1007/s00535-015-1114-8. Epub 2015 Aug 28.
9
Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.瞬时弹性成像（fibroscan）的实用性和减重手术对病态肥胖患者非酒精性脂肪性肝病（NAFLD）的影响。
Surg Obes Relat Dis. 2018 Jan;14(1):81-91. doi: 10.1016/j.soard.2017.09.005. Epub 2017 Sep 11.
10
Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis.减肥手术对非酒精性脂肪性肝病的影响：系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2008 Dec;6(12):1396-402. doi: 10.1016/j.cgh.2008.08.012. Epub 2008 Aug 19.
引用本文的文献
1
NAFLD: A pretransplant and post-transplant conundrum.非酒精性脂肪性肝病：移植前和移植后的难题。
Clin Liver Dis (Hoboken). 2023 May 8;21(4):93-98. doi: 10.1097/CLD.0000000000000021. eCollection 2023 Apr.
本文引用的文献
1
Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.减肥手术与经活检证实的非酒精性脂肪性肝炎患者的肝脏和心血管主要不良结局的关联
JAMA. 2021 Nov 23;326(20):2031-2042. doi: 10.1001/jama.2021.19569.
2
Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort.前瞻性评估大型美国中年队列中非酒精性脂肪性肝病和脂肪性肝炎的患病率。
J Hepatol. 2021 Aug;75(2):284-291. doi: 10.1016/j.jhep.2021.02.034. Epub 2021 Mar 18.
3
Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity.减重手术可降低非酒精性脂肪性肝病和重度肥胖成人的癌症风险。
Gastroenterology. 2021 Jul;161(1):171-184.e10. doi: 10.1053/j.gastro.2021.03.021. Epub 2021 Mar 18.
4
Safety of metabolic and bariatric surgery in obese patients with liver cirrhosis: a systematic review and meta-analysis.肥胖合并肝硬化患者行代谢和减重手术的安全性：系统评价和荟萃分析。
Surg Obes Relat Dis. 2021 Mar;17(3):525-537. doi: 10.1016/j.soard.2020.11.004. Epub 2020 Nov 13.
5
Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis.减重手术可长期解决非酒精性脂肪性肝炎并使肝纤维化消退。
Gastroenterology. 2020 Oct;159(4):1290-1301.e5. doi: 10.1053/j.gastro.2020.06.006. Epub 2020 Jun 15.
6
Histological grading evaluation of non-alcoholic fatty liver disease after bariatric surgery: a retrospective and longitudinal observational cohort study.减重手术后非酒精性脂肪性肝病的组织学分级评估：一项回顾性和纵向观察性队列研究。
Sci Rep. 2020 May 22;10(1):8496. doi: 10.1038/s41598-020-65556-2.
7
Nonalcoholic Steatohepatitis: A Review.非酒精性脂肪性肝炎：综述。
JAMA. 2020 Mar 24;323(12):1175-1183. doi: 10.1001/jama.2020.2298.
8
Long-term Results of Bariatric Surgery for Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients.日本病态肥胖患者接受减重手术治疗非酒精性脂肪性肝病/非酒精性脂肪性肝炎的长期疗效。
Obes Surg. 2019 Apr;29(4):1195-1201. doi: 10.1007/s11695-018-03641-2.
9
Practical Recommendations of the Obesity Management Task Force of the European Association for the Study of Obesity for the Post-Bariatric Surgery Medical Management.肥胖管理工作组的实用建议肥胖协会对肥胖症的研究后的医疗管理后的肥胖症的医疗管理。
Obes Facts. 2017;10(6):597-632. doi: 10.1159/000481825. Epub 2017 Dec 6.
10
Impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004-2012.肥胖症手术对非酒精性脂肪性肝病患者治疗效果的影响：2004-2012 年全国住院患者样本分析。
Surg Obes Relat Dis. 2018 Jan;14(1):74-80. doi: 10.1016/j.soard.2017.09.511. Epub 2017 Sep 14.
Zotero 插件